معرفی
Matthew Graus is a Research Fellow at the University of Sydney's School of Medical Sciences, affiliated with the Faculty of Medicine and Health. His primary research areas include Developmental Biology, Human Genetics, and Vascular Biology, with a focus on mechanisms underlying cellular reprogramming, RNA-protein interactions, and cardiovascular disorders. He collaborates with institutions such as the Centre for Drug Discovery Innovation.
Although specific educational details are not provided in the text, his publications and grants indicate advanced expertise in molecular and cellular biology. His work spans interdisciplinary fields, combining genetic engineering, stem cell biology, and translational medicine.
Recent articles highlight his contributions to understanding TDP-43 condensates in neurodegeneration, engineering Sox17 for neural stem cell transitions, SOX7-dependent vascular-lymphatic interactions, and novel pharmacological approaches to infantile hemangioma treatment. These studies reflect a trend toward applying molecular genetics to address clinical challenges in vascular and neurological systems.
He is involved in grants such as
- "Enhancing heart repair to treat cardiomyopathies: Directed evolution of human KLF1 to increase cardioregenerative potency" (NHMRC Ideas Grant, 2023)
- "Enhancing heart repair to treat cardiomyopathies" (NSW Health Cardiovascular Collaborative Grants, 2023)
Matthew Graus is part of The Centre for Drug Discovery Innovation, focusing on translating basic biological insights into therapeutic strategies.
